125 mg PALBONAMO (Palbociclib) capsules are a targeted oral anti-cancer therapy used to treat HR-positive, HER2-negative advanced or metastatic breast cancer. It inhibits CDK4/6 enzymes to slow tumor growth and is prescribed alongside hormonal therapies. The standard dosage is one capsule daily for 21 days, followed by 7 days off.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Strength 125 mg
Brand palbonamo
Capsules per Pack 21 Capsules
Usage Breast Cancer
Form Capsule
Pack Type Bottle
Prescription/Non prescription Prescription
Country of Origin Made in India
Brand Name PalboNamo
Product Form Capsules
Composition Palbociclib Capsules
Manufacturer Shivnaam Tredlink LLP
Packaging Type Bottle
Packaging Size 1*21 Capsules
Minimum order quantity: 50 Bottle
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.